3-trans-Hydroxy Norcotinine (CAS 1292911-83-1)

3-trans-Hydroxy Norcotinine has demonstrated promising applications in scientific research. Notably, studies have revealed its potential as a selective antagonist of the α7 nicotinic acetylcholine receptor. By selectively blocking this receptor, 3-trans-Hydroxy Norcotinine may offer insights into the underlying mechanisms and modulation of these processes. The mechanism of action of 3-trans-Hydroxy Norcotinine centers around its interaction with the α7 nicotinic acetylcholine receptor, which functions as a ligand-gated ion channel activated by acetylcholine or other agonists. Activation of the receptor prompts the opening of the channel, enabling the entry of positively charged ions into the cell, subsequently leading to cell membrane depolarization and initiation of downstream signaling pathways. As an antagonist of the α7 nicotinic acetylcholine receptor, 3-trans-Hydroxy Norcotinine binds to the receptor without activating it. By doing so, it hinders the binding of acetylcholine or other agonists, effectively blocking the receptor′s activity. Consequently, the influx of positively charged ions is impeded, leading to the disruption of downstream signaling pathways.